Orbital Infiltration in a Patient with Waldenstr öm Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature
The use of specific inhibitory drugs of intracellular signaling pathways (such as Bruton-Kinase inhibitors) for the treatment of Waldenstr öm ' s macroglobulinemia (WM) is a recognized risk factor forAspergillus spp. infections. The overlapping clinical manifestations of the two diseases may require the involvement of different medical specialties.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Authors: Riccardo Paggi, Francesca Mariotti, Jessica Mencarini, Silvia Bresci, Irene Capolmi, Filippo Bartalesi, Beatrice Borchi, Luca Nassi, Alessandro Maria Vannucchi, Alessandro Bartoloni Source Type: research
More News: Hematology | Infectious Diseases | Macroglobulinemia | Men | Waldenstrom's Macroglobulinemia